Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Major Depressive Disorder
Related studies linked through entity extraction aliases.
Do Antidepressants Induce Metabolic Syndromes METADAP Study
- Status
- COMPLETED
- Phase
- NA
Study of Adolescence and Depression
- Status
- COMPLETED
- Phase
- PHASE3
Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major Depression
- Status
- COMPLETED
- Phase
- PHASE2
Does Dual Therapy Hasten Antidepressant Response?
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression
- Status
- COMPLETED
- Phase
- PHASE4
Duloxetine for Perimenopausal Depression
- Status
- COMPLETED
- Phase
- PHASE4
Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2
Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Investigating the Effectiveness of Telepsychiatry for Treating Major Depression in a Chinese American Nursing Home
- Status
- COMPLETED
- Phase
- NA
Duloxetine Versus Paroxetine for Major Depression
- Status
- COMPLETED
- Phase
- PHASE3
eCare for Moods: An Internet-based Management Program
- Status
- COMPLETED
- Phase
- NA
Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)
- Status
- COMPLETED
- Phase
- PHASE4
Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Brain GABA Levels and Treatment Response in Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE4
A Controlled Study to Assess the Effectiveness of Aerobic Exercise as an Augmentation Therapy for Inpatients With Major Depressive Disorder
- Status
- UNKNOWN
- Phase
- NA
A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)
- Status
- COMPLETED
- Phase
- PHASE3
Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism
- Status
- COMPLETED
- Phase
- PHASE4